Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Safepharm Laboratories was a prominent United Kingdom-based contract research organization (CRO) specializing in toxicology, analytical chemistry, and environmental sciences. The company provided critical safety evaluation services to the pharmaceutical, agrochemical, and specialty chemical sectors, assisting clients in meeting complex global regulatory requirements. Known for its deep expertise in non-clinical safety testing, Safepharm played a significant role in supporting REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) registrations and other major regulatory filings. In 2008, the company was acquired by Harlan Laboratories to expand its global footprint in non-clinical research services. Its operations have since been integrated into the broader service offerings of Harlan's successors, including Envigo and currently Inotiv.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Safepharm.